edaravone has been researched along with Arterial Occlusive Diseases in 2 studies
Arterial Occlusive Diseases: Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency.
Excerpt | Relevance | Reference |
---|---|---|
"To investigate the effect of edaravone on depression relief in symptomatic patients with intracranial stenosis and its relationship with the expression of sex hormones." | 9.34 | Edaravone reduces depression severity in patients with symptomatic intracranial stenosis and is associated with the serum expression of sex hormones. ( Deng, M; Jiang, J; Kong, Z; Wang, G; Zhang, Z, 2020) |
"To investigate the effect of edaravone on depression relief in symptomatic patients with intracranial stenosis and its relationship with the expression of sex hormones." | 5.34 | Edaravone reduces depression severity in patients with symptomatic intracranial stenosis and is associated with the serum expression of sex hormones. ( Deng, M; Jiang, J; Kong, Z; Wang, G; Zhang, Z, 2020) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Kong, Z | 1 |
Jiang, J | 1 |
Deng, M | 1 |
Zhang, Z | 1 |
Wang, G | 1 |
Watanabe, M | 1 |
Masaoka, N | 1 |
Nakajima, Y | 1 |
Nagaishi, M | 1 |
Yamamoto, T | 1 |
1 trial available for edaravone and Arterial Occlusive Diseases
Article | Year |
---|---|
Edaravone reduces depression severity in patients with symptomatic intracranial stenosis and is associated with the serum expression of sex hormones.
Topics: Arterial Occlusive Diseases; Brain; Depression; Edaravone; Estradiol; Female; Follicle Stimulating H | 2020 |
1 other study available for edaravone and Arterial Occlusive Diseases
Article | Year |
---|---|
Changes of expression of glucose transporters in the fetal lamb brain after MCI-186 administration to the maternal circulation with 10-min persistent umbilical cord occlusion.
Topics: Animals; Antipyrine; Arterial Occlusive Diseases; Brain; Drug Evaluation, Preclinical; Edaravone; Fe | 2009 |